Follow

⚕️We have around 30 million people living with rare diseases, in Europe alone. This is a major health subject that must be dealt with as a priority by lawmakers and all key stakeholders.
One way to address this is by ensuring that there is enough public support to research and innovation activities, to complement and compensate for any flaws in the efforts being made by the private sector.
Sharing medical information, case studies, and the results of research and innovation activities done by public institutions will benefit the prevention and treatment of all diseases.
Yesterday, at the
nitter.cz/Screen4Rare
event.
nitter.cz/Kympouropoulos
nitter.cz/BillyKelleherEU
nitter.cz/EPPGroup
nitter.cz/psdparleuropeu
nitter.cz/ppdpsd

🐦🔗: nitter.cz/mgracacarvalho/statu

[2023-12-07 13:38 UTC]

· · mirror-bot · 0 · 0 · 0
Sign in to participate in the conversation
Mastodon

A Mastodon forum for the discussion of European Union matters. Not run by the EU. Powered by PleromaBot, Nitter and PrivacyDev.net.